GP MHN

GP MHN BY GENEZA PHARMACEUTICALS

Tablets

DRUG COMPOSITION

1 tablet contains:
 - active substance: methylhydroxynandrolone 5 mg;
 - auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

Oral Anabolic Androgenic Steroid.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: 12 Hours
Routes of administration: by mouth
Dosage forms: (Men): 10-30 mg/day; (Women): -
Acne: yes
Water retention: no
High blood pressure: perhaps
Hepatotoxicity: high
Aromatase: no
Decreased HPTA function (own testosterone production): yes
Anabolic activity: 1304%
Androgenic activity: 281%
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

5 mg tablets.
50 pillstablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

Geneza Pharmaceuticals
Europe